Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD - authors' reply

被引：0
|
作者：
Ben-Horin, S. [1 ,2 ,3 ,4 ]
Chowers, Y. [1 ,2 ,3 ,4 ]
机构：
[1] Tel Aviv Univ, Chaim Sheba Med Ctr, Dept Gastroenterol, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Sch Med, Haifa, Israel
[4] Technion Israel Inst Technol, Rambam Hlth Care Campus, Haifa, Israel
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2012年 / 36卷 / 05期
关键词：
D O I：
10.1111/j.1365-2036.2012.05215.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：501 / 501
页数：1
相关论文
共 50 条
  • [1] Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD
    Steenholdt, C.
    Brynskov, J.
    Bendtzen, K.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) : 499 - 500
  • [2] Letter: detection of infliximab levels and anti-infliximab antibodies - comparison of three different assays; authors' reply
    Buurman, D. J.
    Vande Casteele, N.
    Sturkenboom, M. G. G.
    Kleibeuker, J. H.
    Vermeire, S.
    van der Kleij, D.
    Rispens, T.
    Gils, A.
    Dijkstra, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (02) : 282 - 282
  • [3] The clinical and immunological significance of low level of infliximab in the absence of anti-infliximab antibodies in patients with IBD
    Ungar, B.
    Anafy, A.
    Yavzori, M.
    Picard, O.
    Fudim, E.
    Kopylov, U.
    Ron, Y.
    Yanai, H.
    Dotan, I.
    Chowers, Y.
    Eliakim, R.
    Ben-Horin, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S113 - S113
  • [4] The Clinical and Immunological Significance of Low Level of Infliximab in the Absence of Anti-Infliximab Antibodies in Patients With IBD
    Ungar, Bella
    Anafy, Adi
    Kopylov, Uri
    Ron, Yulia
    Yanai, Henit
    Dotan, Iris
    Chowers, Yehuda
    Eliakim, Abraham R.
    Ben-Horin, Shomron
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S245 - S245
  • [5] Anti-infliximab antibodies in RA patients treated with infliximab.
    Wolbink, GJ
    Lems, WF
    Nurmohamed, MT
    Vis, M
    Voskuyl, AE
    Stapel, S
    de Groot, E
    Tak, PP
    Dijkmans, BA
    Aarden, L
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S187 - S187
  • [6] Letter: detection of infliximab levels and anti-infliximab antibodies comparison of three different assays
    Parussini, E.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (02) : 281 - 281
  • [7] Anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 385 - 386
  • [8] Commentary: detection of infliximab levels and anti-infliximab antibodies
    Seow, C. H.
    Panaccione, R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 153 - 154
  • [9] Detection of anti-infliximab antibodies in Slovak IBD patients and its costs saving effect
    Raffac, Stefan
    Gombosova, Laura
    Gabzdilova, Juliana
    Novotna, Lucia
    Sajtyova, Katarina
    Pekarova, Timea
    Kopolovets, Ivan
    Toth, Stefan
    [J]. NEUROENDOCRINOLOGY LETTERS, 2017, 38 : 5 - 9
  • [10] Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease
    Zitomersky, Naamah
    Chi, Lisa
    Liu, Enju
    Bray, Kurtis R.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    Snapper, Scott B.
    Bousvaros, Athos
    Silvester, Jocelyn A.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (02): : 261 - 271
12345